NCT05150756View on ClinicalTrials.gov

Intraoperative Lidocaine Infusion as a Sole Analgesic Versus Morphine in Laparoscopic Gastric Bypass Surgery

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

July 28, 2022

Study Completion Date

September 20, 2022

Conditions
Pain, Postoperative
Interventions
DRUG

Lidocaine Hydrochloride 2% Intravenous Solution [XYLOCAINE]

At induction of anesthesia, patients will receive a loading dose of 1.5mg/kg lidocaine hydrochloride 2% slowly over 3 min followed by IV infusion of 2mg/kg/hr lidocaine hydrochloride 2% till the end of surgery

DRUG

morphine sulphate (10mg/ ml ampoule)

At induction of anesthesia, patients will receive a loading dose of IV 0.1mg/kg morphine sulphate slowly over 3 minutes followed by IV infusion of normal saline via infusion pump. The infusion will be continued till the end of surgery

Trial Locations (1)

Unknown

Ain-Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05150756 - Intraoperative Lidocaine Infusion as a Sole Analgesic Versus Morphine in Laparoscopic Gastric Bypass Surgery | Biotech Hunter | Biotech Hunter